Latest filing published 12 Mar 2026 for Integra Lifesciences Holdings CORP, €19k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Michael J. McBreen on record concern Integra Lifesciences Holdings Corp, in the capacity of chief executive. In total, 19 filings cover trades dated from 1 June 2021 to 10 March 2026.
On the market, this insider has only sold: 4 sales, €587k in total. Other entries cover 15 share grants.
Most recently, on 12 March 2026, the filings show a share grant worth €19k in Integra Lifesciences Holdings Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 19 declarations